Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.1K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

428
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
428
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

267
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

369
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
369
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

686
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
686
Coronary Circulation01:21

Coronary Circulation

7.2K
The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive Assessment of Vasospastic Angina using Coronary CT Angiography: Synergistic Value of the Presence of Myocardial Bridge, Perivascular inflammation, and Myocardial Extracellular Volume Fraction.

European heart journal. Cardiovascular Imaging·2026
Same author

A case of cardiac lymphangioma: diagnosis suggested by cardiac CT and MRI and successful conservative management.

Journal of cardiology cases·2026
Same author

Association of Multimodal Intracoronary Imaging-Derived Plaque Morphology with the Pathophysiological Disease Patterns Assessed by the Quantitative Flow Ratio-Pullback Pressure Gradient.

Journal of atherosclerosis and thrombosis·2026
Same author

Urgent Transcatheter Aortic Valve Replacement in Acute Heparin-Induced Thrombocytopenia Using Argatroban and Crossover Technique.

The Canadian journal of cardiology·2026
Same author

Determinants of myocardial extracellular volume fraction derived from coronary CT angiography in patients with chronic coronary syndrome.

Journal of cardiovascular computed tomography·2026
Same author

Comprehensive Endotyping of Patients With Angina and Nonobstructive Coronary Arteries: A Report From the J-CMD.

Journal of the American Heart Association·2026

Related Experiment Video

Updated: Jan 31, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

3.2K

High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary

Rikuta Hamaya1, Tomoki Horie1, Taishi Yonetsu2

  • 1Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1, Otsuno, Tsuchiura, Ibaraki, Japan.

Heart and Vessels
|January 3, 2019
PubMed
Summary

Percutaneous coronary intervention (PCI) may lower high-sensitivity cardiac troponin-I (hs-cTnI) levels in some stable coronary artery disease patients. A decrease in hs-cTnI after PCI was associated with a lower incidence of major adverse cardiac events (MACE).

Keywords:
High-sensitivity cardiac troponinMultivessel diseasePercutaneous coronary interventionQuantitative flow ratioStable coronary artery disease

More Related Videos

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
06:39

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice

Published on: April 13, 2015

15.7K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

939

Related Experiment Videos

Last Updated: Jan 31, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

3.2K
Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
06:39

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice

Published on: April 13, 2015

15.7K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

939

Area of Science:

  • Cardiology
  • Biomarkers
  • Interventional Cardiology

Background:

  • Baseline cardiac troponin, particularly high-sensitivity cardiac troponin-I (hs-cTnI), predicts major adverse cardiac events (MACE).
  • The prognostic value of percutaneous coronary intervention (PCI) in stable coronary artery disease (CAD) and its effect on baseline troponin remain unclear.

Purpose of the Study:

  • To investigate the impact of PCI on hs-cTnI levels in stable CAD patients.
  • To assess the association between changes in hs-cTnI levels post-PCI and MACE incidence.

Main Methods:

  • 401 stable CAD patients undergoing PCI had hs-cTnI measured twice before PCI and once 10 months after PCI.
  • Patients were grouped based on hs-cTnI change (Increase/No change/Decrease) relative to pre-PCI variability.
  • Association between hs-cTnI change and MACE incidence was analyzed, with multivariable adjustment.

Main Results:

  • A 'Decrease' group (77 patients) showed significantly higher pre-PCI hs-cTnI but the lowest MACE incidence (p < 0.001).
  • Hs-cTnI increase post-PCI was associated with higher MACE (HR 2.069), while decrease was associated with lower MACE (HR 0.143) compared to no change.
  • Predictors of hs-cTnI change included pre-PCI hs-cTnI, hs-cTnI variability, dyslipidemia, multivessel disease, and complex lesions.

Conclusions:

  • PCI can reduce hs-cTnI levels in a subset of stable CAD patients.
  • A decrease in hs-cTnI following PCI may indicate a favorable prognosis and reduced MACE risk.